Referring Hospitalized Smokers to Outpatient Quit Services: A Randomized Trial
- PMID: 27647061
- PMCID: PMC5031367
- DOI: 10.1016/j.amepre.2016.06.014
Referring Hospitalized Smokers to Outpatient Quit Services: A Randomized Trial
Abstract
Introduction: Linking outpatient cessation services to bedside counseling for hospitalized smokers can improve long-run quit rates. Adding an assisted referral (AR) offer to a tobacco treatment specialist consult service fits the team approach to care in U.S. hospitals.
Design: A two-arm patient-randomized trial tested the effectiveness of adding an AR offer to outpatient smoking-cessation services and interactive voice recognition (AR+IVR) follow-up to a usual care (UC) tobacco-cessation consult for hospitalized smokers.
Setting/participants: Over 24 months (November 2011-November 2013), 898 hospitalized adult smokers interested in quitting smoking were recruited from three large hospitals in the Portland, Oregon, area: an integrated group model HMO (n=622), a community hospital (n=195), and an academic health center (n=81).
Intervention: Tobacco treatment specialists identified smokers and provided an intensive bedside tobacco use assessment and cessation consultation (UC). AR+IVR recipients also received proactive ARs to available outpatient counseling programs and medications, and linked patients to a tailored IVR telephone follow-up system.
Main outcome measures: The primary outcome was self-reported 30-day abstinence at 6-month follow-up. Secondary outcomes included self-reported and continuous abstinence and biochemically confirmed 7-day abstinence at 6 months. Follow-up was completed in September 2014; data were analyzed in 2015.
Results: A total of 597 and 301 hospitalized smokers were randomized to AR+IVR and UC, respectively. AR+IVR and UC recipients received 19.3 and 17.0 minutes of bedside counseling (p=0.372), respectively. Most (58%) AR+IVR patients accepted referrals for counseling, 43% accepted medications, and 28% accepted both. Self-reported 30-day abstinence for AR+IVR (17.9%) and UC (17.3%) were not statistically significant (p=0.569). Differences in 7-day, continuous, and biochemically confirmed abstinence by treatment group also were insignificant, overall and adjusting for site.
Conclusions: Adding an AR to outpatient counseling and medications did not increase cigarette abstinence at 6 months compared to UC alone.
Trial registration: ClinicalTrials.gov NCT01236079.
Copyright © 2016 American Journal of Preventive Medicine. All rights reserved.
Figures
References
-
- U.S. DHHS . The health consequences of smoking: 50 years of progress: A report of the surgeon general. U.S. DHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
-
- Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking. Am J Prev Med. 2015;48(3):326–333. http://dx.doi.org/10.1016/j.amepre.2014.10.012. - DOI - PMC - PubMed
-
- Fiore MC, Jaén CR, Baker TB, et al. Clinical Practice Guideline. U.S. DHHS. Public Health Service; Rockville, MD: May, 2008. Treating Tobacco Use and Dependence: 2008 Update.
-
- Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA. 2012;308(15):1573–1580. http://dx.doi.org/10.1001/jama.2012.13043. - DOI - PMC - PubMed
-
- Orleans CT, Woolf SH, Rothemich SF, Marks JS, Isham GJ. The top priority: Building a better system for tobacco-cessation counseling. Am J Prev Med. 2006;31(1):103–106. http://dx.doi.org/10.1016/j.amepre.2006.03.015. - DOI - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials